Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 31.3% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price fell 31.3% during mid-day trading on Wednesday . The company traded as low as C$0.14 and last traded at C$0.17. 1,643,425 shares were traded during mid-day trading, an increase of 198% from the average session volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Price Performance

The business’s 50 day moving average is C$0.10 and its 200-day moving average is C$0.07. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm has a market capitalization of C$23.01 million, a P/E ratio of -16.50 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.